Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Irritable Bowel Syndrome, February 2024

Free Subscription


Abstracts

Retrieve all available abstracts of the following 78 articles:
HTML format


 

Single Articles

  1. RAY JC, Matharu M, Hutton E
    Relationship of migraine and other forms of chronic pain.
    Handb Clin Neurol. 2024;199:517-524.
    PubMed    
    Abstract available

  2. ZUNDELL MP, Merola JF, Gottlieb AB
    A New Tool to Improve Communication Between Hidradenitis Suppurativa Patients and Health Care Providers.
    J Drugs Dermatol. 2024;23:105-109.
    PubMed    
    Abstract available

  3. RESEARCH AND PRACTICE G
    Retracted: Association of Fecal Microbiota with Irritable Bowel Syndrome-Diarrhea and Effect of Traditional Chinese Medicine for Its Management.
    Gastroenterol Res Pract. 2024;2024:9797032.
    PubMed    
    Abstract available

  4. MAGHSOOD AH, Kayedimajd S, Motavallihaghi S, Abedian R, et al
    Irritable Bowel Syndrome Associated with Blastocystis hominis or Without Relationship to It? A Case-Control Study and Minireview.
    Acta Parasitol. 2024 Feb 1. doi: 10.1007/s11686-023-00787.
    PubMed    
    Abstract available

  5. INTERNATIONAL EM
    Retracted: Efficacy and Mechanism of Trimebutine Maleate Combined with Lactulose in the Treatment of Constipation-Predominant Irritable Bowel Syndrome in the Elderly.
    Emerg Med Int. 2024;2024:9837328.
    PubMed    
    Abstract available

  6. KAMP K, Yang PL, Friedman E, Lopez A, et al
    Formative Evaluation of a Comprehensive Self-Management Intervention for Irritable Bowel Syndrome, Comorbid Anxiety, and Depression: Mixed Methods Study.
    JMIR Form Res. 2024;8:e43286.
    PubMed    
    Abstract available

  7. WU BY, Xu P, Cheng L, Wang QQ, et al
    The alteration of mucosal bile acid profile is associated with nerve growth factor expression in mast cells and bowel symptoms in diarrhea-predominant irritable bowel syndrome.
    Clin Exp Immunol. 2024 Jan 30:uxae006. doi: 10.1093.
    PubMed    
    Abstract available

  8. OLDROYD P, Oldroyd S, Meng M, Makwana R, et al
    Stretchable Device for Simultaneous Measurements of Contractility and Electrophysiology of Neuromuscular Tissue in The Gastrointestinal Tract.
    Adv Mater. 2024 Jan 30:e2312735. doi: 10.1002/adma.202312735.
    PubMed    
    Abstract available

  9. WENG CC, Suarez C, Cheang SE, Couture G, et al
    Quantifying Gut Microbial Short-Chain Fatty Acids and Their Isotopomers in Mechanistic Studies Using a Rapid, Readily Expandable LC-MS Platform.
    Anal Chem. 2024 Jan 30. doi: 10.1021/acs.analchem.3c04352.
    PubMed    
    Abstract available

  10. KERN D, Lindfors E, Laler L, Lindfors A, et al
    Ashtangayoga for irritable bowel syndrome in a primary care setting: A feasibility study.
    Neurogastroenterol Motil. 2024 Jan 29:e14744. doi: 10.1111/nmo.14744.
    PubMed    
    Abstract available

  11. MULLISH BH, Michael DR, Dabcheva M, Webberley TS, et al
    A double-blind, randomized, placebo-controlled study assessing the impact of probiotic supplementation on the symptoms of irritable bowel syndrome in females.
    Neurogastroenterol Motil. 2024 Jan 29:e14751. doi: 10.1111/nmo.14751.
    PubMed    
    Abstract available

  12. LIN W, Zhou Y, Liu Y, Liu C, et al
    Dorsoventral hippocampus distinctly modulates visceral sensitivity and anxiety behaviors in male IBS-like rats.
    J Neurosci Res. 2024;102.
    PubMed    
    Abstract available

  13. JANSCH S, Evdokimov D, Egenolf N, Meyer Zu Altenschildesche C, et al
    Distinguishing fibromyalgia syndrome from small fiber neuropathy: a clinical guide.
    Pain Rep. 2024;9:e1136.
    PubMed    
    Abstract available

  14. CONIC RRZ, Vasilopoulos T, Devulapally K, Przkora R, et al
    Hypertension and urologic chronic pelvic pain syndrome: An analysis of MAPP-I data.
    BMC Urol. 2024;24:21.
    PubMed    
    Abstract available

  15. ALVAREZ AA, Palka JM, Khan DA
    Severe Multiple Drug Intolerance Syndrome in Fibromyalgia and Irritable Bowel Syndrome.
    J Allergy Clin Immunol Pract. 2024 Jan 24:S2213-2198(24)00073.
    PubMed    
    Abstract available

  16. DAI C, Huang YH, Jiang M
    Prolonged Gastrointestinal Manifestations After Recovery From COVID-19.
    Clin Gastroenterol Hepatol. 2024 Jan 24:S1542-3565(24)00092.
    PubMed    


  17. HINOJOSA-GONZALEZ DE, Salgado-Garza G, Tellez-Garcia E, Escarcega-Bordagaray JA, et al
    Blood salvage and autotransfusion during orthotopic liver transplantation for hepatocellular carcinoma: A systematic review and meta-analysis.
    Clin Transplant. 2023 Dec 8:e15222. doi: 10.1111/ctr.15222.
    PubMed    
    Abstract available

  18. CORSETTI M, Ballou S
    Symptom Subgroups Taking Into Account Psychological Burden Predicts Irritable Bowel Syndrome Disease Impact and Burden: A Step Forward?
    Clin Gastroenterol Hepatol. 2024;22:237-240.
    PubMed    


  19. MATSUEDA K, Fukudo S, Ogishima M, Naito Y, et al
    Efficacy and safety of peppermint oil for the treatment in Japanese patients with irritable bowel syndrome: a prospective, open-label, and single-arm study.
    Biopsychosoc Med. 2024;18:3.
    PubMed    
    Abstract available

  20. RUIZ-SANCHEZ C, Escudero-Lopez B, Fernandez-Pachon MS
    Evaluation of the efficacy of probiotics as treatment in irritable bowel syndrome.
    Endocrinol Diabetes Nutr (Engl Ed). 2024 Feb 7:S2530-0180(24)00003.
    PubMed    
    Abstract available

  21. ZHAN K, Wu H, Xu Y, Rao K, et al
    The function of the gut microbiota-bile acid-TGR5 axis in diarrhea-predominant irritable bowel syndrome.
    mSystems. 2024 Feb 8:e0129923. doi: 10.1128/msystems.01299.
    PubMed    
    Abstract available

  22. SAVARINO EV, Chiarioni G
    Improved diagnosis of faecal incontinence in the gastroenterology domain: The time to act has come.
    United European Gastroenterol J. 2024 Feb 8. doi: 10.1002/ueg2.12546.
    PubMed    


  23. JORGENSEN T, Dantoft TM, Petersen MW, Gormsen L, et al
    Is reduced heart rate variability associated with functional somatic disorders? A cross-sectional population-based study; DanFunD.
    BMJ Open. 2024;14:e073909.
    PubMed    
    Abstract available

  24. KOBAYASHI R, Inoue K, Sugino S, Hirose R, et al
    Efficacy of Glycicumarin and Isoliquiritigenin in Suppressing Colonic Peristalsis in Both an Animal Model and a Clinical Trial.
    Biol Pharm Bull. 2024;47:373-382.
    PubMed    
    Abstract available

  25. PATEL M G, Borah N, Kumar B, Rai R, et al
    MEDITERRANEAN DIET AND ITS IMPACT ON THE ILLNESS CHARACTERISTIC OF YOUTH WITH IRRITABLE BOWEL CONDITION.
    Georgian Med News. 2023;:62-66.
    PubMed    
    Abstract available

  26. NASS BYS, Dibbets P, Markus CR
    Mediating effect of coping dispositions on the association between trauma and gastrointestinal symptoms.
    Stress Health. 2024 Feb 7:e3380. doi: 10.1002/smi.3380.
    PubMed    
    Abstract available

  27. LACKNER JM
    Innovative cognitive behavioral therapies for irritable bowel syndrome: processes, predictors, platforms, and outcomes.
    Pain. 2024 Feb 6. doi: 10.1097/j.pain.0000000000003186.
    PubMed    


  28. ABUGHARBIEH HMI, Alshareef RB, Ghazaleh RA, Jobran AWM, et al
    Arabic websites assessment of irritable bowel syndrome: How trustworthy are they? A cross-sectional study.
    Health Sci Rep. 2024;7:e1819.
    PubMed    
    Abstract available

  29. EKHOLM M, Krouwels M, Knittle K
    Examining interactions of illness perceptions, avoidance behavior and patient status in predicting quality of life among people with irritable bowel syndrome.
    Health Psychol Behav Med. 2024;12:2311986.
    PubMed    
    Abstract available

  30. KIM YS, Lee JY, Kim JW, Kang SJ, et al
    Masculinity, Rather Than Biological Sex, Is Associated With Psychological Comorbidities in Patients With Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2024 Feb 7. doi: 10.5056/jnm23012.
    PubMed    
    Abstract available

  31. KHASAWNEH M, Shaikh FA, Ng CE, Black CJ, et al
    Utility of irritable bowel syndrome subtypes and most troublesome symptom in predicting disease impact and burden.
    Neurogastroenterol Motil. 2024 Feb 6:e14756. doi: 10.1111/nmo.14756.
    PubMed    
    Abstract available

  32. SHAHKARAM H, Yaztappeh JS, Sadeghi A, Kianimoghadam AS, et al
    Comparing the effectiveness of transdiagnostic treatment with acceptance and commitment therapy on emotional disorders, rumination, and life satisfaction in patients with irritable bowel syndrome: a randomized clinical trial.
    BMC Gastroenterol. 2024;24:66.
    PubMed    
    Abstract available

  33. NESHATIAN L, Grant G, Fernandez-Becker N, Yuan Y, et al
    The association between vitamin-D deficiency and fecal incontinence.
    Neurogastroenterol Motil. 2024 Feb 5:e14753. doi: 10.1111/nmo.14753.
    PubMed    
    Abstract available

  34. SHAHID Y, Sohail Z, Urrehman A, Uddin Z, et al
    Microscopic Colitis in a Young Male: Unveiling the Rarity.
    Cureus. 2024;16:e51638.
    PubMed    
    Abstract available

  35. MCLEOD L, Ervin C, Fehnel SE, Eremenco S, et al
    Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation in a Prospective Observational Study.
    Value Health. 2024 Feb 2:S1098-3015(24)00042-1. doi: 10.1016/j.jval.2024.
    PubMed    
    Abstract available

  36. ROSS SM
    Irritable Bowel Syndrome: Effects of a Probiotic Combination in Reducing Stress Response and Symptoms Associated With Irritable Bowel Syndrome.
    Holist Nurs Pract. 2024;38:120-122.
    PubMed    


  37. BIN-ALAMER O, Abou-Al-Shaar H, Niranjan A, Hadjipanayis CG, et al
    Straining the Limits of the Brain: Arteriovenous Malformation Rupture Case Report in the Context of Chronic Constipation.
    Stroke. 2024 Feb 16. doi: 10.1161/STROKEAHA.123.045730.
    PubMed    


  38. OMOLOYE A, Weisenburger S, Lehner MD, Gronier B, et al
    Menthacarin treatment attenuates nociception in models of visceral hypersensitivity.
    Neurogastroenterol Motil. 2024 Feb 15:e14760. doi: 10.1111/nmo.14760.
    PubMed    
    Abstract available

  39. AGUILAR A, Benslaiman B, Serra J
    Effect of Iberogast (STW5) on tolerance to colonic gas in patients with irritable bowel syndrome: A randomized, double-blind, placebo control clinical trial.
    Neurogastroenterol Motil. 2024 Feb 15:e14765. doi: 10.1111/nmo.14765.
    PubMed    
    Abstract available

  40. KLEINSTAUBER M, Schroder A, Daehler S, Pallesen KJ, et al
    Aetiological Understanding of Fibromyalgia, Irritable Bowel Syndrome, Chronic Fatigue Syndrome and Classificatory Analogues: A Systematic Umbrella Review.
    Clin Psychol Eur. 2023;5:e11179.
    PubMed    
    Abstract available

  41. SIYAL M, Abbas Z, Amir MR, Qadeer MA, et al
    Saccharomyces cerevisiae for abdominal pain and discomfort in irritable bowel syndrome patients.
    Pak J Med Sci. 2024;40.
    PubMed    
    Abstract available

  42. HAMILTON MJ
    Mast Cell Activation Syndrome and Gut Dysfunction: Diagnosis and Management.
    Curr Gastroenterol Rep. 2024 Feb 14. doi: 10.1007/s11894-024-00924.
    PubMed    
    Abstract available

  43. DUAN GB, Wang JW, Sun HH, Dong ZY, et al
    Overexpression of EphB2 in the basolateral amygdala is crucial for inducing visceral pain sensitization in rats subjected to water avoidance stress.
    CNS Neurosci Ther. 2024;30:e14611.
    PubMed    
    Abstract available

  44. ZHANG T, Chen Y, Li X, Zhang J, et al
    Genetic associations and potential mediators between psychiatric disorders and irritable bowel syndrome: a Mendelian randomization study with mediation analysis.
    Front Psychiatry. 2024;15:1279266.
    PubMed    
    Abstract available

  45. SHIN A, Xing Y, Waseem MR, Siwiec R, et al
    Microbiota-Short Chain Fatty Acid Relationships and Microbial Substrate Preferences Vary Across the Spectrum of Irritable Bowel Syndrome (IBS).
    medRxiv. 2024 Feb 1:2024.01.31.24302084. doi: 10.1101/2024.01.31.24302084.
    PubMed    
    Abstract available

  46. LESER T, Baker A
    Bifidobacterium adolescentis - a beneficial microbe.
    Benef Microbes. 2023;14:525-551.
    PubMed    
    Abstract available

  47. TUFVESSON H, Hamrefors V, Fedorowski A, Hansson M, et al
    Gastrointestinal symptoms in patients with postural orthostatic tachycardia syndrome in relation to hemodynamic findings and immunological factors.
    Front Physiol. 2024;15:1342351.
    PubMed    
    Abstract available

  48. ROTH B, Ohlsson B
    Microscopic colitis found together with celiac disease in a female population is associated with one episode of lymphocytic colitis.
    BMC Gastroenterol. 2024;24:70.
    PubMed    
    Abstract available

  49. NORDIN E, Landberg R, Hellstrom PM, Brunius C, et al
    Exploration of differential responses to FODMAPs and gluten in people with irritable bowel syndrome- a double-blind randomized cross-over challenge study.
    Metabolomics. 2024;20:21.
    PubMed    
    Abstract available

  50. ZHU H, Wang W, Li Y
    The interplay between microbiota and brain-gut axis in epilepsy treatment.
    Front Pharmacol. 2024;15:1276551.
    PubMed    
    Abstract available

  51. SELIMOVIC A, Mekic N, Terzic S, Cosickic A, et al
    Functional gastrointestinal disorders in children: a single centre experience.
    Med Glas (Zenica). 2024;21:112-117.
    PubMed    
    Abstract available

  52. BERTIN L, Zanconato M, Crepaldi M, Marasco G, et al
    The Role of the FODMAP Diet in IBS.
    Nutrients. 2024;16:370.
    PubMed    
    Abstract available

  53. SALVATORE S, Carlino M, Sestito S, Concolino D, et al
    Nutraceuticals and Pain Disorders of the Gut-Brain Interaction in Infants and Children: A Narrative Review and Practical Insights.
    Nutrients. 2024;16:349.
    PubMed    
    Abstract available

  54. HAMREFORS V, Kahn F, Holmqvist M, Carlson K, et al
    Gut microbiota composition is altered in postural orthostatic tachycardia syndrome and post-acute COVID-19 syndrome.
    Sci Rep. 2024;14:3389.
    PubMed    
    Abstract available

  55. VERDU EF, Vanner S
    The IBS bug-pain connection.
    Gut Microbes. 2024;16:2308956.
    PubMed    


  56. WHELAN K, Bancil AS, Lindsay JO, Chassaing B, et al
    Ultra-processed foods and food additives in gut health and disease.
    Nat Rev Gastroenterol Hepatol. 2024 Feb 22. doi: 10.1038/s41575-024-00893.
    PubMed    
    Abstract available

  57. VAN TILBURG MAL, Monis EL, Braumann RE, Fleishman K, et al
    Hypnotherapy as a medical treatment: Evidence-based or pseudoscience?
    Complement Ther Clin Pract. 2024;55:101841.
    PubMed    
    Abstract available

  58. KULIAVIENE I, Gelman S, Kupcinskas J
    Patient-Physician Relationship in Irritable Bowel Syndrome: Review on Empathy and Stigma.
    J Gastrointestin Liver Dis. 2024 Feb 22. doi: 10.15403/jgld-5018.
    PubMed    
    Abstract available

  59. LEWIS D
    An Updated Review of Exocrine Pancreatic Insufficiency Prevalence finds EPI to be More Common in General Population than Rates of Co-Conditions.
    J Gastrointestin Liver Dis. 2024 Feb 22. doi: 10.15403/jgld-5005.
    PubMed    
    Abstract available

  60. BARDOS G
    Irritable bowel syndrome (IBS): could we decide what is behind?
    Biol Futur. 2024 Feb 22. doi: 10.1007/s42977-024-00205.
    PubMed    
    Abstract available

  61. WANG C, Zhang J, Han F, Liu D, et al
    No evidence for a causal link between Helicobacter pylori infection and Irritable bowel syndrome: a Mendelian randomization study.
    Front Microbiol. 2024;14:1268492.
    PubMed    
    Abstract available

  62. STEINRUECKE M, Mason I, Keen M, McWhirter L, et al
    Pain and functional neurological disorder: a systematic review and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2024 Feb 21:jnnp-2023-332810.
    PubMed    
    Abstract available

  63. ANNUNZIATA G, Santaniello MG, Cristiano NMV, Chieffi S, et al
    Low-FODMAP diet and hidradenitis suppurativa: the role of nutritionists in the management of dermato-endocrine disorders.
    Minerva Endocrinol (Torino). 2024 Feb 21. doi: 10.23736/S2724-6507.23.04088.
    PubMed    
    Abstract available

  64. KALLUR RK, Madapati S, Mathur A, Bhattacharya S, et al
    The role of Weizmannia (Bacillus) coagulans LMG S-31876 in treating IBS-diarrhea.
    Front Nutr. 2024;10:1310462.
    PubMed    
    Abstract available

  65. LIU J, Dai Q, Qu T, Ma J, et al
    Ameliorating effects of transcutaneous auricular vagus nerve stimulation on a mouse model of constipation-predominant irritable bowel syndrome.
    Neurobiol Dis. 2024;193:106440.
    PubMed    
    Abstract available

  66. MARILD K, Soderling J, Lebwohl B, Green PH, et al
    ASSOCIATION BETWEEN CELIAC DISEASE AND IRRITABLE BOWEL SYNDROME: A NATIONWIDE COHORT STUDY.
    Clin Gastroenterol Hepatol. 2024 Feb 15:S1542-3565(24)00201.
    PubMed    
    Abstract available

  67. MOZAFFARI S, Nikfar S, Abdollahi M
    Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs.
    Expert Opin Investig Drugs. 2024 Feb 23:1-10. doi: 10.1080/13543784.2024.2320703
    PubMed    
    Abstract available


  68. A Qualitative Study of the Experiences of Complementary and Alternative Medicine of Patients With IBS-C: Erratum.
    Holist Nurs Pract. 2024;38:108.
    PubMed    


  69. LEMBO AJ, Chey WD, Harris LA, Frazier R, et al
    Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis.
    Am J Gastroenterol. 2024 Jan 31. doi: 10.14309/ajg.0000000000002685.
    PubMed    
    Abstract available

  70. GUPTA T, Cash BD
    In primary care, second-line IBS therapy with amitriptyline vs. placebo reduced symptoms at 6 mo.
    Ann Intern Med. 2024 Feb 6. doi: 10.7326/J23-0122.
    PubMed    
    Abstract available

  71. XU E, Vilella RC, Bashir A, Sizar O, et al
    CH(4), H(2)S, and H(2)O: How Do They Relate to Microbiome-Driven IBS Pathogenesis?
    Dig Dis Sci. 2024;69:326-327.
    PubMed    
    Abstract available

  72. FORD AC, Vanner S, Kashyap PC, Nasser Y, et al
    CHRONIC VISCERAL PAIN: NEW PERIPHERAL MECHANISTIC INSIGHTS AND RESULTING TREATMENTS.
    Gastroenterology. 2024 Feb 5:S0016-5085(24)00132.
    PubMed    
    Abstract available

  73. TACK J, Carbone F, Chang L, Lacy BE, et al
    Patient reported outcomes in Disorders of Gut-Brain Interaction.
    Gastroenterology. 2024 Feb 1:S0016-5085(24)00124.
    PubMed    
    Abstract available

  74. FORD AC
    Ebastine for the treatment of irritable bowel syndrome: old drug, new tricks?
    Gut. 2024 Feb 1:gutjnl-2024-331927. doi: 10.1136/gutjnl-2024-331927.
    PubMed    


  75. HO FF, Sun H, Zheng H, Wong DCN, et al
    Association of healthy lifestyle behaviours with incident irritable bowel syndrome: a large population-based prospective cohort study.
    Gut. 2024 Feb 20:gutjnl-2023-331254. doi: 10.1136/gutjnl-2023-331254.
    PubMed    
    Abstract available

  76. SHAH E, Eswaran S, Harer K, Lee A, et al
    Percutaneous electrical nerve field stimulation for adolescents with irritable bowel syndrome: Cost-benefit and cost-minimization analysis.
    J Pediatr Gastroenterol Nutr. 2024 Jan 15. doi: 10.1002/jpn3.12118.
    PubMed    
    Abstract available

  77. DANIALIFAR TF, Chumpitazi BP, Mehta DI, Di Lorenzo C, et al
    Genetic and acquired sucrase-isomaltase deficiency: A clinical review.
    J Pediatr Gastroenterol Nutr. 2024 Feb 8. doi: 10.1002/jpn3.12151.
    PubMed    
    Abstract available

  78. LLUANSI A, Lliros M, Carreras-Torres R, Bahi A, et al
    Impact of bread diet on intestinal dysbiosis and irritable bowel syndrome symptoms in quiescent ulcerative colitis: A pilot study.
    PLoS One. 2024;19:e0297836.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.


;